Study of PRP, PPP, and Bone Marrow Aspirate Concentrate Effects on Recovery After Hip Arthroscopy for Labral Injuries

What this Trial Is About

Researchers are evaluating the effect of applying a combination of platelet-rich plasma PRP, platelet-poor plasma PPP, and bone marrow aspirate concentrate BMAC on functional outcomes after hip arthroscopy for acetabular labral pathologies. The study aims to determine whether this application improves patient-reported outcomes and reduces arthritic burden in patients undergoing surgery for labral tears and cartilage damage. This randomized controlled trial offers level I evidence to compare standard hip arthroscopy with and without PRPPPPBMAC application. Participants will undergo hip arthroscopy under general anesthesia, where the surgeon will assess damage to the labrum and cartilage. Patients with minimal damage will receive standard care without PRPPPPBMAC and form a control group, while those with more significant damage will be randomized to either receive PRPPPPBMAC application or no additional treatment. Bone marrow will be aspirated from the ilium through arthroscopic portals during surgery for those in the treatment group. Participants will be blinded to their treatment allocation. Throughout the study, participants will complete various patient-reported outcome measures, including pain assessments and hip function scores, before surgery and at intervals up to 24 months and beyond. The study will also track physical exams, imaging results, and any subsequent surgeries. Follow-up will continue for up to 20 years postoperatively, with surveys collected via email or phone to monitor long-term outcomes and safety.

Effect of PRP, PPP, & BMAC on Functional Outcomes Following Hip Arthroscopy for Acetabular Labral Pathologies